@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.org/fhir/uv/emedicinal-product-info/Composition/cfsb1651231019153> a fhir:Composition ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "cfsb1651231019153"] ; # 
  fhir:language [ fhir:v "en"] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p><b>Generated Narrative: Composition</b><a name=\"cfsb1651231019153\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource Composition &quot;cfsb1651231019153&quot;  (Language &quot;en&quot;) </p></div><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000155539)</span></p><p><b>date</b>: 2022-04-29 13:28:17+0000</p><p><b>author</b>: <a href=\"Organization-cfsb1665505132093.html\">Organization/cfsb1665505132093</a> &quot;Gilead Sciences Ireland UC&quot;</p><p><b>title</b>: TEST PURPOSES ONLY - Biktarvy 50 mg/200 mg/25 mg film-coated tablets</p><h3>Attesters</h3><table class=\"grid\"><tr><td>-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td>*</td><td>Official <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-composition-attestation-mode.html\">Composition Attestation Mode</a>#official)</span></td><td>2002-08-01 13:28:17+0000</td></tr></table></div>"
  ] ; # 
  fhir:status [ fhir:v "final"] ; # 
  fhir:type [
     fhir:coding ( [
       fhir:system [ fhir:v "https://spor.ema.europa.eu/"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "100000155539" ]
     ] ) ;
     fhir:text [ fhir:v "Package Leaflet" ]
  ] ; # 
  fhir:subject ( [
     fhir:link <http://hl7.org/fhir/uv/emedicinal-product-info/RegulatedAuthorization/cfsb1665505019066> ;
     fhir:reference [ fhir:v "RegulatedAuthorization/cfsb1665505019066" ]
  ] ) ; # 
  fhir:date [ fhir:v "2022-04-29T13:28:17Z"^^xsd:dateTime] ; # 
  fhir:author ( [
     fhir:link <http://hl7.org/fhir/uv/emedicinal-product-info/Organization/cfsb1665505132093> ;
     fhir:reference [ fhir:v "Organization/cfsb1665505132093" ]
  ] ) ; # 
  fhir:title [ fhir:v "TEST PURPOSES ONLY - Biktarvy 50 mg/200 mg/25 mg film-coated tablets"] ; # 
  fhir:attester ( [
     fhir:mode [
       fhir:coding ( [
         fhir:system [ fhir:v "http://hl7.org/fhir/composition-attestation-mode"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "official" ]
       ] )
     ] ;
     fhir:time [ fhir:v "2002-08-01T13:28:17Z"^^xsd:dateTime ]
  ] ) ; # 
  fhir:section ( [
     fhir:title [ fhir:v "B. Package Leaflet" ] ;
     fhir:code [
       fhir:coding ( [
         fhir:system [ fhir:v "https://spor.ema.europa.eu/"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "100000155538" ]
       ] ) ;
       fhir:text [ fhir:v "B. PACKAGE LEAFLET" ]
     ] ;
     fhir:text [
       fhir:status [ fhir:v "additional" ] ;
       fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\">Package leaflet: Information for the patient Dovato 50 mg/300 mg film-coated tablets dolutegravir/lamivudine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.<ul><li>Keep this leaflet. You may need to read it again.</li><li>If you have any further questions, ask your doctor or pharmacist.</li><li>This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</li><li>If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.</li></ul></div>"
     ]
  ] [
     fhir:title [ fhir:v "What is in this leaflet" ] ;
     fhir:code [
       fhir:coding ( [
         fhir:system [ fhir:v "https://spor.ema.europa.eu/"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "100000155538-0" ]
       ] ) ;
       fhir:text [ fhir:v "B. PACKAGE LEAFLET" ]
     ] ;
     fhir:text [
       fhir:status [ fhir:v "additional" ] ;
       fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\">What in this leaflet<ol><li>What Dovato is and what it is used for</li><li>What you need to know before you take Dovato</li><li>How to take Dovato</li><li>Possible side effects</li><li>How to store Dovato</li><li>Contents of the pack and other information</li></ol></div>"
     ]
  ] [
     fhir:title [ fhir:v "1. What Dovato is and what it is used for" ] ;
     fhir:code [
       fhir:coding ( [
         fhir:system [ fhir:v "https://spor.ema.europa.eu/"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "100000155538-1" ]
       ] ) ;
       fhir:text [ fhir:v "B. PACKAGE LEAFLET" ]
     ] ;
     fhir:text [
       fhir:status [ fhir:v "additional" ] ;
       fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>1. What Dovato is and what it is used for</b> Dovato is a medicine that contains two active ingredients used to treat human immunodeficiency virus (HIV) infection: dolutegravir and lamivudine.</div>"
     ]
  ] [
     fhir:title [ fhir:v "2. What you need to know before you take Dovato" ] ;
     fhir:code [
       fhir:coding ( [
         fhir:system [ fhir:v "https://spor.ema.europa.eu/"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "100000155538-2" ]
       ] ) ;
       fhir:text [ fhir:v "B. PACKAGE LEAFLET" ]
     ] ;
     fhir:text [
       fhir:status [ fhir:v "additional" ] ;
       fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>2. What you need to know before you take Dovato</b> Do not take Dovato<ul><li>if you are allergic (hypersensitive) to dolutegravir or lamivudine or any of the other ingredients of this medicine (listed in section 6).</li><li>If you are taking a medicine called fampridine (also known as dalfampridine; used in multiple sclerosis).</li></ul></div>"
     ]
  ] [
     fhir:title [ fhir:v "3. How to take Dovato" ] ;
     fhir:code [
       fhir:coding ( [
         fhir:system [ fhir:v "https://spor.ema.europa.eu/"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "100000155538-3" ]
       ] ) ;
       fhir:text [ fhir:v "B. PACKAGE LEAFLET" ]
     ] ;
     fhir:text [
       fhir:status [ fhir:v "additional" ] ;
       fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>How to take Dovato</b><p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure</p><ul><li>The recommended dose of Dovato is <b>one tablet once a day.</b></li><li>If you are taking a medicine called fampridine (also known as dalfampridine; used in multiple sclerosis).</li></ul></div>"
     ]
  ] [
     fhir:title [ fhir:v "4. Possible side effects" ] ;
     fhir:code [
       fhir:coding ( [
         fhir:system [ fhir:v "https://spor.ema.europa.eu/"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "100000155538-4" ]
       ] ) ;
       fhir:text [ fhir:v "B. PACKAGE LEAFLET" ]
     ] ;
     fhir:text [
       fhir:status [ fhir:v "additional" ] ;
       fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>4. Possible side effects</b></p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them,<b>so it is very important to talk to your doctor about any changes in your health</b></p></div>"
     ]
  ] [
     fhir:title [ fhir:v "5. How to store Dovato" ] ;
     fhir:code [
       fhir:coding ( [
         fhir:system [ fhir:v "https://spor.ema.europa.eu/"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "100000155538-5" ]
       ] ) ;
       fhir:text [ fhir:v "B. PACKAGE LEAFLET" ]
     ] ;
     fhir:text [
       fhir:status [ fhir:v "additional" ] ;
       fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>5. How to store Dovato</b><p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the carton and bottle after EXP. The expiry date refers to the last day of that month.</p><p>This medicine does not require any special storage conditions.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p></div>"
     ]
  ] [
     fhir:title [ fhir:v "6. Contents of the pack and other information" ] ;
     fhir:code [
       fhir:coding ( [
         fhir:system [ fhir:v "https://spor.ema.europa.eu/"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "100000155538-6" ]
       ] ) ;
       fhir:text [ fhir:v "B. PACKAGE LEAFLET" ]
     ] ;
     fhir:text [
       fhir:status [ fhir:v "additional" ] ;
       fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><b>6. Contents of the pack and other information</b> <b>What Dovato contains</b><ul><li>The active substances are dolutegravir and lamivudine. Each tablet contains dolutegravir sodium equivalent to 50 mg dolutegravir and 300 mg lamivudine.</li><li>The other ingredients are microcrystalline cellulose, sodium starch glycolate, magnesium stearate, mannitol (E421), povidone (K29/32), sodium stearyl fumarate, hypromellose (E464), macrogol, titanium dioxide (E171).</li><li>This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodiumfree’.</li></ul></div>"
     ]
  ] ) . # 

<http://hl7.org/fhir/uv/emedicinal-product-info/RegulatedAuthorization/cfsb1665505019066> a fhir:uv .

<http://hl7.org/fhir/uv/emedicinal-product-info/Organization/cfsb1665505132093> a fhir:uv .

# -------------------------------------------------------------------------------------

